{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:55:10Z","timestamp":1770422110926,"version":"3.49.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373966"],"award-info":[{"award-number":["82373966"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40262-025-01605-1","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T03:57:31Z","timestamp":1765684651000},"page":"313-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Validation of a Chinese Obesity-Specific Physiological Database for PBPK Modeling"],"prefix":"10.1007","volume":"65","author":[{"given":"Ruwei","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6711-4251","authenticated-orcid":false,"given":"Qi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"issue":"suppl_1","key":"1605_CR1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/advances\/nmy055","volume":"10","author":"B Caballero","year":"2019","unstructured":"Caballero B. Humans against obesity: who will win? Adv Nutr. 2019;10(suppl_1):S4\u20139.","journal-title":"Adv Nutr"},{"issue":"1","key":"1605_CR2","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1038\/s41467-023-39282-y","volume":"14","author":"M Recalde","year":"2023","unstructured":"Recalde M, Pistillo A, Davila-Batista V, Leitzmann M, Romieu I, Viallon V, et al. Longitudinal body mass index and cancer risk: a cohort study of 2.6 million Catalan adults. Nat Commun. 2023;14(1):3816.","journal-title":"Nat Commun"},{"key":"1605_CR3","unstructured":"Report on nutrition and chronic disease status of Chinese residents (2020). Acta Nutr Sin. 2020;42(6):521."},{"key":"1605_CR4","unstructured":"World Obesity Federation. World Obesity Atlas 2023. 2023 [cited; https:\/\/data.worldobesity.org\/publications\/?cat=19."},{"issue":"2","key":"1605_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40262-024-01442-8","volume":"64","author":"M Prager","year":"2025","unstructured":"Prager M, Al Jalali V, Zeitlinger M. Clinical pharmacokinetics of antitubercular drugs in the overweight and obese population: implications for dosage adjustments. Clin Pharmacokinet. 2025;64(2):193\u2013214.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1605_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/clpt.2011.104","volume":"90","author":"R Jain","year":"2011","unstructured":"Jain R, Chung SM, Jain L, Khurana M, Lau SW, Lee JE, et al. Implications of obesity for drug therapy: limitations and challenges. Clin Pharmacol Ther. 2011;90(1):77\u201389.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1605_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40262-022-01194-3","volume":"62","author":"M Berton","year":"2023","unstructured":"Berton M, Bettonte S, Stader F, Battegay M, Marzolini C. Physiologically based pharmacokinetic modelling to identify physiological and drug parameters driving pharmacokinetics in obese individuals. Clin Pharmacokinet. 2023;62(2):277\u201395.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"1605_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s40262-022-01132-3","volume":"61","author":"M Berton","year":"2022","unstructured":"Berton M, Bettonte S, Stader F, Battegay M, Marzolini C. Repository describing the anatomical, physiological, and biological changes in an obese population to inform physiologically based pharmacokinetic models. Clin Pharmacokinet. 2022;61(9):1251\u201370.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"1605_CR9","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1111\/bcp.15349","volume":"88","author":"KE Kvitne","year":"2022","unstructured":"Kvitne KE, Krogstad V, Wegler C, Johnson LK, Kringen MK, Hovd MH, et al. Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity. Br J Clin Pharmacol. 2022;88(9):4121\u201333.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1605_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/17425255.2018.1440287","volume":"14","author":"C Smit","year":"2018","unstructured":"Smit C, De Hoogd S, Bruggemann RJM, Knibbe CAJ. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters. Expert Opin Drug Metab Toxicol. 2018;14(3):275\u201385.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"1605_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/17425255.2024.2388690","volume":"20","author":"R Yang","year":"2024","unstructured":"Yang R, Ding Q, Ding J, Zhu L, Pei Q. Physiologically based pharmacokinetic modeling in obesity: applications and challenges. Expert Opin Drug Metab Toxicol. 2024;20(8):805\u201316.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"1605_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cpt.37","volume":"97","author":"HM Jones","year":"2015","unstructured":"Jones HM, Chen Y, Gibson C, Heimbach T, Parrott N, Peters SA, et al. Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective. Clin Pharmacol Ther. 2015;97(3):247\u201362.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1605_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10928-007-9053-5","volume":"34","author":"S Willmann","year":"2007","unstructured":"Willmann S, H\u00f6hn K, Edginton A, Sevestre M, Solodenko J, Weiss W, et al. Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs. J Pharmacokinet Pharmacodyn. 2007;34(3):401\u201331.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1605_CR14","unstructured":"National Physical Fitness and Health Database. 2006\u20132011 [cited]. http:\/\/cnphd.bmicc.cn\/chs\/cn\/analysis.php."},{"key":"1605_CR15","unstructured":"Compilation of anatomical, physiological and metabolic characteristics for a reference Asian man Volume 2: Country Reports. Vienna: International Atomic Energy Agency; 1998."},{"issue":"3","key":"1605_CR16","first-page":"200","volume":"12","author":"Branch CMAHM, Society CN, China Association for International Exchange and Promotion of Health Care RMB, Foundation CHP, Center ZCN","year":"2018","unstructured":"Branch CMAHM, Society CN, China Association for International Exchange and Promotion of Health Care RMB, Foundation CHP, Center ZCN. Expert consensus & standard on weight management for overweight or obese people. Chin J Health Manag. 2018;12(3):200\u20137.","journal-title":"Chin J Health Manag"},{"issue":"6","key":"1605_CR17","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785\u2013805.","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"1605_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jrsm.1429","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Luo D, Weng H, Zeng XT, Lin L, Chu H, et al. Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. 2020;11(5):641\u201354.","journal-title":"Res Synth Methods"},{"issue":"7","key":"1605_CR19","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/09622802231172043","volume":"32","author":"J Shi","year":"2023","unstructured":"Shi J, Luo D, Wan X, Liu Y, Liu J, Bian Z, et al. Detecting the skewness of data from the five-number summary and its application in meta-analysis. Stat Methods Med Res. 2023;32(7):1338\u201360.","journal-title":"Stat Methods Med Res"},{"issue":"21","key":"1605_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006447","volume":"96","author":"S Gholamzadeh","year":"2017","unstructured":"Gholamzadeh S, Zarenezhad M, Montazeri M, Zareikordshooli M, Sadeghi G, Malekpour A, et al. Statistical analysis of organ morphometric parameters and weights in South Iranian adult autopsies. Medicine (Baltimore). 2017;96(21):e6447.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1605_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/PAF.0b013e31823d29ad","volume":"33","author":"DK Molina","year":"2012","unstructured":"Molina DK, DiMaio VJ. Normal organ weights in men: part II\u2014the brain, lungs, liver, spleen, and kidneys. Am J Forensic Med Pathol. 2012;33(4):368\u201372.","journal-title":"Am J Forensic Med Pathol"},{"issue":"8","key":"1605_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","volume":"56","author":"MAS Weerink","year":"2017","unstructured":"Weerink MAS, Struys M, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893\u2013913.","journal-title":"Clin Pharmacokinet"},{"key":"1605_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/00365528909091241","volume":"166","author":"C Cederberg","year":"1989","unstructured":"Cederberg C, Andersson T, Sk\u00e5nberg I. Omeprazole: pharmacokinetics and metabolism in man. Scand J Gastroenterol Suppl. 1989;166:33\u201340 (discussion 1-2).","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"12","key":"1605_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","volume":"57","author":"MM Sahinovic","year":"2018","unstructured":"Sahinovic MM, Struys M, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57(12):1539\u201358.","journal-title":"Clin Pharmacokinet"},{"key":"1605_CR25","first-page":"217","volume":"02","author":"Z Liu","year":"1981","unstructured":"Liu Z, Ji Z. Statistics on the average weight of some normal organs in 4100 autopsies. Guangdong Anat Bull. 1981;02:217\u201326.","journal-title":"Guangdong Anat Bull"},{"key":"1605_CR26","first-page":"24","volume":"01","author":"D Luo","year":"1991","unstructured":"Luo D, Li Z, Zhou Y. A study of organ weights in 1269 cases of the elderly. Pract Geriatr. 1991;01:24\u20136.","journal-title":"Pract Geriatr"},{"issue":"4","key":"1605_CR27","first-page":"7","volume":"15","author":"J Wan","year":"1995","unstructured":"Wan J, Li B. Weight reference values of major organs of Chinese people. Chin J Radiat Med Prot. 1995;15(4):7.","journal-title":"Chin J Radiat Med Prot"},{"issue":"1","key":"1605_CR28","first-page":"2","volume":"23","author":"Z Li","year":"2006","unstructured":"Li Z, Huang G. Detailed table of organ weights for each age group in China. J Guangxi Med Univ. 2006;23(1):2.","journal-title":"J Guangxi Med Univ"},{"key":"1605_CR29","unstructured":"SUN E, Wang Y, Wang Q, Li J. A study of the weight of the Chinese human brain. J China Med Univ. 1980."},{"issue":"12","key":"1605_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s40262-013-0089-y","volume":"52","author":"ZE Barter","year":"2013","unstructured":"Barter ZE, Tucker GT, Rowland-Yeo K. Differences in cytochrome P450-mediated pharmacokinetics between Chinese and Caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling. Clin Pharmacokinet. 2013;52(12):1085\u2013100.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"1605_CR31","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.3390\/ijerph19074238","volume":"19","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Wang Z, Maruyama H, Onoda K, Huang Q. Body fat percentage and normal-weight obesity in the Chinese population: development of a simple evaluation indicator using anthropometric measurements. Int J Environ Res Public Health. 2022;19(7):4238.","journal-title":"Int J Environ Res Public Health"},{"issue":"13","key":"1605_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1476-511X-13-113","volume":"12","author":"XC Wang","year":"2014","unstructured":"Wang XC, Liu H, Huang YY, Sun H, Bu L, Qu S. Head fat is a novel method of measuring metabolic disorder in Chinese obese patients. Lipids Health Dis. 2014;12(13):113.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"1605_CR33","volume":"13","author":"S Wen","year":"2021","unstructured":"Wen S, Xu S, Nguyen T, Gong M, Yan H, Zhou L. Metabolic effects on body components after a three-month physical intervention in overweight medical staff. Cureus. 2021;13(10):e19027.","journal-title":"Cureus"},{"issue":"34","key":"1605_CR34","first-page":"4","volume":"88","author":"Y Pu","year":"2008","unstructured":"Pu Y, He H, Zhao Z, Chen J, Ni Y, Zhong J, et al. Evaluation of quantitative visceral fat testing in abdominal obesity and its clinical significance. Natl Med J China. 2008;88(34):4.","journal-title":"Natl Med J China"},{"issue":"4","key":"1605_CR35","first-page":"4","volume":"32","author":"J Wang","year":"2003","unstructured":"Wang J, Wang X. Applied equations for the measurement of body fat content in obese individuals by the bioresistive resistance method. J Hyg Res. 2003;32(4):4.","journal-title":"J Hyg Res."},{"issue":"9","key":"1605_CR36","first-page":"3","volume":"30","author":"Y Ji","year":"2022","unstructured":"Ji Y, Lv M, Guo X. Effects of HIIT with different training intervals on body composition in overweight or obese adult males. Bull Sport Sci Technol. 2022;30(9):3.","journal-title":"Bull Sport Sci Technol."},{"issue":"5","key":"1605_CR37","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/sj.ijo.0801612","volume":"25","author":"M He","year":"2001","unstructured":"He M, Tan KC, Li ET, Kung AW. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int J Obes Relat Metab Disord. 2001;25(5):748\u201352.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"11","key":"1605_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051098","volume":"7","author":"F Wang","year":"2012","unstructured":"Wang F, Ma X, Hao Y, Yang R, Ni J, Xiao Y, et al. Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance. PLoS ONE. 2012;7(11):e51098.","journal-title":"PLoS ONE"},{"issue":"2","key":"1605_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3177\/jnsv.69.121","volume":"69","author":"S Katsuya","year":"2023","unstructured":"Katsuya S, Kawata Y, Goto T, Tsubota J. Daily intake of D-\u03b2-hydroxybutyric acid (D-BHB) reduces body fat in Japanese adult participants: a randomized, double-blind, placebo-controlled study. J Nutr Sci Vitaminol (Tokyo). 2023;69(2):121\u20138.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"3","key":"1605_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.soard.2015.07.003","volume":"12","author":"CLY Ngoh","year":"2016","unstructured":"Ngoh CLY, So JBY, Tiong HY, Shabbir A, Teo BW. Effect of weight loss after bariatric surgery on kidney function in a multiethnic Asian population. Surg Obes Relat Dis. 2016;12(3):600\u20135.","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"1605_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nut.2011.09.008","volume":"28","author":"SC Chen","year":"2012","unstructured":"Chen SC, Lin YH, Huang HP, Hsu WL, Houng JY, Huang CK. Effect of conjugated linoleic acid supplementation on weight loss and body fat composition in a Chinese population. Nutrition. 2012;28(5):559\u201365.","journal-title":"Nutrition"},{"issue":"2","key":"1605_CR42","first-page":"96","volume":"24","author":"L Wang","year":"2016","unstructured":"Wang L, Yu D, Wang M, Cheng B, Sun M. Diet and body composition in overweight and obese patients. Chin J Clin Nutr. 2016;24(2):96\u2013100.","journal-title":"Chin J Clin Nutr"},{"issue":"21","key":"1605_CR43","first-page":"1456","volume":"85","author":"L Chen","year":"2005","unstructured":"Chen L, Xiang KS, Jia WP, Lu JX, Bao YQ, Lu HJ. Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study. Zhonghua Yi Xue Za Zhi. 2005;85(21):1456\u20139.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"1605_CR44","first-page":"103","volume":"18","author":"WP Jia","year":"2005","unstructured":"Jia WP, Yang M, Shao XY, Bao YQ, Lu JX, Xiang KS. Resting energy expenditure and its relationship with patterns of obesity and visceral fat area in Chinese adults. Biomed Environ Sci. 2005;18(2):103\u20137.","journal-title":"Biomed Environ Sci"},{"key":"1605_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111939","volume":"108","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Maruyama H, Onoda K, Zhou Y, Huang Q, Hu C, et al. Body mass index combined with (waist\u00a0+\u00a0hip)\/height accurately screened for normal-weight obesity in Chinese young adults. Nutrition. 2023;108:111939.","journal-title":"Nutrition"},{"issue":"5","key":"1605_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nutres.2015.04.001","volume":"35","author":"MJ Kim","year":"2015","unstructured":"Kim MJ, Hwang JH, Ko HJ, Na HB, Kim JH. Lemon detox diet reduced body fat, insulin resistance, and serum hs-CRP level without hematological changes in overweight Korean women. Nutr Res. 2015;35(5):409\u201320.","journal-title":"Nutr Res"},{"issue":"3","key":"1605_CR47","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/03014460701275749","volume":"34","author":"S Wu","year":"2007","unstructured":"Wu S, Lei SF, Chen XD, Tan LJ, Jian WX, Deng FY, et al. The contributions of lean tissue mass and fat mass to bone geometric adaptation at the femoral neck in Chinese overweight adults. Ann Hum Biol. 2007;34(3):344\u201353.","journal-title":"Ann Hum Biol"},{"issue":"1","key":"1605_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.ijo.0800361","volume":"21","author":"ML Kortelainen","year":"1997","unstructured":"Kortelainen ML, Sarkioja T. Coronary atherosclerosis and myocardial hypertrophy in relation to body fat distribution in healthy women: an autopsy study on 33 violent deaths. Int J Obes Relat Metab Disord. 1997;21(1):43\u20139.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"1605_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.ijo.0801852","volume":"26","author":"ML Kortelainen","year":"2002","unstructured":"Kortelainen ML. Myocardial infarction and coronary pathology in severely obese people examined at autopsy. Int J Obes Relat Metab Disord. 2002;26(1):73\u20139.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"8","key":"1605_CR50","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/sj.ijo.0800960","volume":"23","author":"ML Kortelainen","year":"1999","unstructured":"Kortelainen ML, S\u00e4rkioja T. Coronary atherosclerosis associated with body structure and obesity in 599 women aged between 15 and 50 years. Int J Obes Relat Metab Disord. 1999;23(8):838\u201344.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"12","key":"1605_CR51","first-page":"1315","volume":"65","author":"SS Fatima","year":"2015","unstructured":"Fatima SS, Farooq S, Tauni MA, Irfan O, Alam F. Effect of raised body fat on vitamin D, leptin and bone mass. J Pak Med Assoc. 2015;65(12):1315\u20139.","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"1605_CR52","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/j.orcp.2013.07.002","volume":"8","author":"M Takihata","year":"2014","unstructured":"Takihata M, Nakamura A, Aoki K, Kimura M, Sekino Y, Inamori M, et al. Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients. Obes Res Clin Pract. 2014;8(4):e331\u20138.","journal-title":"Obes Res Clin Pract"},{"issue":"5","key":"1605_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1507\/endocrj.EJ16-0321","volume":"64","author":"A Umemura","year":"2017","unstructured":"Umemura A, Sasaki A, Nitta H, Baba S, Ando T, Kajiwara T, et al. Pancreas volume reduction and metabolic effects in Japanese patients with severe obesity following laparoscopic sleeve gastrectomy. Endocr J. 2017;64(5):487\u201398.","journal-title":"Endocr J"},{"issue":"5","key":"1605_CR54","volume":"25","author":"L Wang","year":"2022","unstructured":"Wang L, Zhao Y, Wang Z, Yu Y, Wang J, Jiang T. Safety and learning curve of da Vinci robotic single anastomotic duodeno-ileal bypass combined with sleeve gastrectomy for the treatment of obese patients. Chin J Gastrointest Surg. 2022;25(5):8.","journal-title":"Chin J Gastrointest Surg"},{"issue":"6","key":"1605_CR55","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/healthcare11060923","volume":"11","author":"SH Wang","year":"2023","unstructured":"Wang SH, Lin HL, Huang CC, Chen YH. Comparison of hemodynamic and cerebral oxygenation responses during exercise between normal-weight and overweight men. Healthcare (Basel). 2023;11(6):923.","journal-title":"Healthcare (Basel)."},{"issue":"7","key":"1605_CR56","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/jpm13071042","volume":"13","author":"H Ghasim","year":"2023","unstructured":"Ghasim H, Rouini M, Safari S, Larti F, Khoshayand M, Gholami K, et al. Impact of obesity and bariatric surgery on metabolic enzymes and P-glycoprotein activity using the Geneva cocktail approach. J Pers Med. 2023;13(7):1042.","journal-title":"J Pers Med."},{"issue":"11","key":"1605_CR57","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1111\/cts.13394","volume":"15","author":"KE Kvitne","year":"2022","unstructured":"Kvitne KE, Asberg A, Johnson LK, Wegler C, Hertel JK, Artursson P, et al. Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity. Clin Transl Sci. 2022;15(11):2685\u201396.","journal-title":"Clin Transl Sci"},{"issue":"7","key":"1605_CR58","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s11095-023-03531-y","volume":"40","author":"S Li","year":"2023","unstructured":"Li S, Xie L, Yang L, Jiang L, Yang Y, Zhi H, et al. Prediction of omeprazole pharmacokinetics and its inhibition on gastric acid secretion in humans using physiologically based pharmacokinetic-pharmacodynamic model characterizing CYP2C19 polymorphisms. Pharm Res. 2023;40(7):1735\u201350.","journal-title":"Pharm Res"},{"issue":"8","key":"1605_CR59","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00228-018-2461-1","volume":"74","author":"P Uusalo","year":"2018","unstructured":"Uusalo P, Al-Ramahi D, Tilli I, Aantaa RA, Scheinin M, Saari TI. Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers. Eur J Clin Pharmacol. 2018;74(8):1047\u201354.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1605_CR60","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1365-2710.2012.01357.x","volume":"37","author":"S Lee","year":"2012","unstructured":"Lee S, Kim BH, Lim K, Stalker D, Wisemandle W, Shin SG, et al. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. J Clin Pharm Ther. 2012;37(6):698\u2013703.","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"1605_CR61","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00228-011-1002-y","volume":"67","author":"T Iirola","year":"2011","unstructured":"Iirola T, Vilo S, Manner T, Aantaa R, Lahtinen M, Scheinin M, et al. Bioavailability of dexmedetomidine after intranasal administration. Eur J Clin Pharmacol. 2011;67(8):825\u201331.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1605_CR62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF03259205","volume":"2","author":"T Andersson","year":"1990","unstructured":"Andersson T, Regrdh CG. Pharmacokinetics of omeprazole and metabolites following single intravenous and oral doses of 40 and 80mg. Drug Investig. 1990;2(4):255\u201363.","journal-title":"Drug Investig"},{"issue":"2","key":"1605_CR63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF00280061","volume":"39","author":"T Andersson","year":"1990","unstructured":"Andersson T, Cederberg C, Regardh CG, Skanberg I. Pharmacokinetics of various single intravenous and oral doses of omeprazole. Eur J Clin Pharmacol. 1990;39(2):195\u20137.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1605_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00228-006-0251-7","volume":"63","author":"T Uno","year":"2007","unstructured":"Uno T, Niioka T, Hayakari M, Yasui-Furukori N, Sugawara K, Tateishi T. Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations. Eur J Clin Pharmacol. 2007;63(2):143\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1605_CR65","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0091270003251391","volume":"43","author":"F Abad-Santos","year":"2003","unstructured":"Abad-Santos F, Galvez-Mugica MA, Santos MA, Novalbos J, Gallego-Sandin S, Mendez P, et al. Pharmacokinetics and pharmacodynamics of a single bolus of propofol 2% in healthy volunteers. J Clin Pharmacol. 2003;43(4):397\u2013405.","journal-title":"J Clin Pharmacol"},{"key":"1605_CR66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/00044011-200222070-00001","volume":"22","author":"C Jungheinrich","year":"2002","unstructured":"Jungheinrich C, Scharpf R, Wargenau M, et al. Pharmacokinetics of the generic formulation propofol 1% fresenius in comparison with the original formulation (Disoprivan\u00ae 1%). Clin Drug Investig. 2002;22:417\u201327.","journal-title":"Clin Drug Investig"},{"issue":"12","key":"1605_CR67","first-page":"4","volume":"30","author":"C Shu","year":"2011","unstructured":"Shu C, Huang L, Ge M, Li W. Pharmacokinetics of dexmedetomidine hydrochloride injection in healthy humans. Herald Med. 2011;30(12):4.","journal-title":"Herald Med"},{"issue":"5","key":"1605_CR68","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jpba.2009.06.012","volume":"50","author":"W Li","year":"2009","unstructured":"Li W, Zhang Z, Wu L, Tian Y, Feng S, Chen Y. Determination of dexmedetomidine in human plasma using high performance liquid chromatography coupled with tandem mass spectrometric detection: application to a pharmacokinetic study. J Pharm Biomed Anal. 2009;50(5):897\u2013904.","journal-title":"J Pharm Biomed Anal"},{"key":"1605_CR69","first-page":"248","volume":"37","author":"D Zhou","year":"2016","unstructured":"Zhou D, Xu B, Tu W, Zhang X, Chen B, Ren L. In vivo pharmacokinetic study of dexmedetomidine in patients with different levels of obesity. J Jinan Univ (Nat Sci Med Ed). 2016;37:248.","journal-title":"J Jinan Univ (Nat Sci Med Ed)."},{"issue":"6","key":"1605_CR70","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00228-010-0821-6","volume":"66","author":"Y Wang","year":"2010","unstructured":"Wang Y, Zhang H, Meng L, Wang M, Yuan H, Ou N, et al. Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers. Eur J Clin Pharmacol. 2010;66(6):563\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"1605_CR71","first-page":"3","volume":"15","author":"Z Li","year":"2000","unstructured":"Li Z, Hu J. Pharmacokinetic and pharmacodynamic study of omeprazole sodium injection in healthy subjects. West China J Pharm Sci. 2000;15(5):3.","journal-title":"West China J Pharm Sci"},{"issue":"4","key":"1605_CR72","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/17512433.2022.2075343","volume":"15","author":"K Chen","year":"2022","unstructured":"Chen K, Luo P, Yang G, Zhu S, Deng C, Ding J, et al. Population pharmacokinetics of omeprazole in obese and normal-weight adults. Expert Rev Clin Pharmacol. 2022;15(4):461\u201371.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"1605_CR73","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1631\/jzus.B1100272","volume":"13","author":"J Liu","year":"2012","unstructured":"Liu J, Shentu JZ, Wu LH, Dou J, Xu QY, Zhou HL, et al. Relative bioavailability and pharmacokinetic comparison of two different enteric formulations of omeprazole. J Zhejiang Univ Sci B. 2012;13(5):348\u201355.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"2","key":"1605_CR74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00228-005-0063-1","volume":"62","author":"HL Qiao","year":"2006","unstructured":"Qiao HL, Hu YR, Tian X, Jia LJ, Gao N, Zhang LR, et al. Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype. Eur J Clin Pharmacol. 2006;62(2):107\u201312.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1605_CR75","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0091270004265702","volume":"44","author":"OQ Yin","year":"2004","unstructured":"Yin OQ, Tomlinson B, Chow AH, Waye MM, Chow MS. Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability. J Clin Pharmacol. 2004;44(6):582\u20139.","journal-title":"J Clin Pharmacol"},{"issue":"002","key":"1605_CR76","first-page":"136","volume":"29","author":"L Yang","year":"2013","unstructured":"Yang L, Yang G, Huang J, Zhang R, Wang Y. Pharmacokinetics and pharmacodynamics of propofol injection in healthy volunteers. Chin J Clin Pharmacol. 2013;29(002):136\u20138.","journal-title":"Chin J Clin Pharmacol"},{"issue":"11","key":"1605_CR77","volume":"17","author":"L Chen","year":"2012","unstructured":"Chen L, Zhou X, Guo X, Su T, Cheng Z. Pharmacokinetic\/pharmacodynamic study of propofol injection in Chinese healthy volunteers. Chin J Clin Pharmacol Ther. 2012;17(11):9.","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"1605_CR78","unstructured":"Kong X, Liu S, Liu R, Yang Z, Yu H, Ai Q, et al. Bioequivalence study of propofol medium\/long-chain fatty milk injection in healthy Chinese subjects. Chin J Clin Pharmacol. 2022(038-010)."},{"issue":"10","key":"1605_CR79","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1124\/dmd.116.071605","volume":"44","author":"D Dong","year":"2016","unstructured":"Dong D, Peng X, Liu J, Qian H, Li J, Wu B. Morbid obesity alters both pharmacokinetics and pharmacodynamics of propofol: dosing recommendation for anesthesia induction. Drug Metab Dispos. 2016;44(10):1579\u201383.","journal-title":"Drug Metab Dispos"},{"issue":"002","key":"1605_CR80","first-page":"99","volume":"000","author":"L Ren","year":"2015","unstructured":"Ren L, Xu B, Li Z, Li L, Tu W. Pharmacokinetics of dexmedetomidine hydrochloride in obese patients undergoing general anesthesia. Chin J Clin Pharmacol. 2015;000(002):99\u2013101.","journal-title":"Chin J Clin Pharmacol"},{"issue":"5","key":"1605_CR81","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","volume":"51","author":"MJ Brill","year":"2012","unstructured":"Brill MJ, Diepstraten J, van Rongen A, van Kralingen S, van den Anker JN, Knibbe CA. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51(5):277\u2013304.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"1605_CR82","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00000433-199009000-00005","volume":"11","author":"R Hanzlick","year":"1990","unstructured":"Hanzlick R, Rydzewski D. Heart weights of white men 20 to 39 years of age. An analysis of 218 autopsy cases. Am J Forensic Med Pathol. 1990;11(3):202\u20134.","journal-title":"Am J Forensic Med Pathol"},{"issue":"2","key":"1605_CR83","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40262-021-01072-4","volume":"61","author":"JG Gerhart","year":"2022","unstructured":"Gerhart JG, Carre\u00f1o FO, Edginton AN, Sinha J, Perrin EM, Kumar KR, et al. Development and evaluation of a virtual population of children with obesity for physiologically based pharmacokinetic modeling. Clin Pharmacokinet. 2022;61(2):307\u201320.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"1605_CR84","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/biomedicines11102851","volume":"11","author":"J Rimboeck","year":"2023","unstructured":"Rimboeck J, Gruber M, Weigl M, Huber P, Lunz D, Petermichl W. Obesity correlates with chronic inflammation of the innate immune system in preeclampsia and HELLP syndrome during pregnancy. Biomedicines. 2023;11(10):2851.","journal-title":"Biomedicines."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01605-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:03:29Z","timestamp":1770379409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01605-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1605"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01605-1","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests relevant to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The data used to support the findings of this study are available from the corresponding author upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"May be available upon reasonable request to the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Qi Pei and Liyong Zhu conceived the idea and designed the study. Qi Pei supervised the project. Ruwei Yang developed the modeling and simulation strategies. Material preparation, data collection, and analysis were performed by Ruwei Yang, Yujie Wen, and Shengnan Zhang. The first draft of the manuscript was written by Ruwei Yang and Yujie Wen. Guoping Yang revised the manuscript critically for valuable intellectual content and proofreading. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}